Join Our Newsletter
|
Contact
|
Glossary
Facebook
Twitter
Linkedin
MENU
MENU
Latest
The Source Blog
Key Issues
Healthcare Markets
Healthcare Costs
Price Transparency
Pharmaceuticals
System Reform
Enforcement
State Action
Overview
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
About
Articles & Reports
Key Issues
All
HEALTHCARE MARKETS
- Provider Network
-- Telehealth or Telemedicine
-- Scope of Practice
-- Any Willing Provider
-- Network Adequacy
-- Tiered Network or Narrow Network
- Competition
-- Antitrust Enforcement
-- Healthcare Consolidation
-- Most Favored Nation (MFN)
-- Certificate of Need (CON)
-- Certificate of Public Advantage (COPA)
-- Anti-Steering or Anti-Tiering
-- Price Manipulation
-- Competitive Bidding
-- Trade Secret
- Rate Regulation
- ACA Marketplace
HEALTHCARE COSTS
- Cost Containment
-- Shared Savings or Right to Shop
-- Reference Pricing
-- Prior Authorization
-- Utilization Review
- Price Gouging
- Cost-Sharing or Out-of-Pocket Costs
- High Deductible Health Plan (HDHP)
- Health Savings Account (HSA) or Health Reimbursement Account (HRA)
- Benefit Design
- Provider Payment
-- Value-Based Payment
-- Bundled Payment
-- Global Payment or Global Budget
-- Capitation
-- Population-Based Payment
-- Shared Risk or Risk-Based Payment
-- Facility Fee
HEALTHCARE SYSTEM REFORM
- Single Payer or Multi-Payer
- Public Option
- Delivery Reform
- Quality or Value-Based Reform
- Managed Competition
- Accountable Care Organization (ACO)
- Medicaid Reform or Medicaid Waiver
- Affordable Care Act (ACA)
- Federal Reform Effort
PRICE AND QUALITY TRANSPARENCY
- All-Payer Claims Database (APCD)
- Gag Clause or Non-Disclosure Agreement
- Surprise Billing or Balance Billing
- Quality Measure
PHARMACEUTICALS
- Drug Pricing
- Drug Formulary
- Pharmacy Benefit Manager (PBM)
- Pharmacy Regulation
-- Clawback Restriction
- Biosimilar or Generic Competition
-- Generic Competition Block or Delay
- Therapeutic Substitution
- Medicaid Pharmaceuticals
- Medicare Part D
- 340B Drug Pricing Program
- Drug Importation
Jurisdiction
All
Federal
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Start Date
End Date
Annals of Internal Medicine
Policy Recommendations for Public Health Plans to Stem the Escalating Costs of Prescription Drugs: A Position Paper From the American College of Physicians
November 12, 2019
Annals of Internal Medicine
Policy Recommendations for Pharmacy Benefit Managers to Stem the Escalating Costs of Prescription Drugs: A Position Paper From the American College of Physicians
November 12, 2019
JAMA Internal Medicine
Markups on Emergency Medicine and Anesthesiology Services in the United States From 2012 to 2016
November 11, 2019
The Commonwealth Fund
What Can the United States Learn from Pharmaceutical Spending Controls in France?
November 11, 2019
Health Affairs
Financial Hardships Of Medicare Beneficiaries With Serious Illness
November 4, 2019
Health Affairs
As Insurers Exit Affordable Care Act Marketplaces, So Do Consumers
November 4, 2019
Kaiser Family Foundation
How Much Do Medicare Beneficiaries Spend Out of Pocket on Health Care?
November 4, 2019
Health Affairs
Changes In Physician Consolidation With The Spread Of Accountable Care Organizations
November 4, 2019
The Commonwealth Fund
Seeing Fraud and Misleading Marketing, States Warn Consumers About Alternative Health Insurance Products
October 30, 2019
Committee for a Responsible Federal Budget
Choices for Financing Medicare for All: A Preliminary Analysis
October 28, 2019
The Urban Institute
Is There Potential for a Public Option to Reduce Premiums of Competing Insurers?
October 24, 2019
USC-Brookings Schaeffer Initiative for Health Policy
Experience with New York’s arbitration process for surprise out-of-network bills
October 24, 2019
Center on Health Insurance Reforms
Assessing Responses to Increased Provider Consolidation
October 24, 2019
California Health Care Foundation
A Close Look at Medi-Cal Managed Care: Quality, Access, and the Provider’s Experience Under the Regional Model
October 23, 2019
California Health Care Foundation
A Close Look at Medi-Cal Managed Care: Quality, Access, and the Provider’s Experience Under Geographic Managed Care
October 23, 2019
Bipartisan Policy Center
Examining Two Approaches to U.S. Drug Pricing: International Prices and Therapeutic Equivalency
October 22, 2019
Next
